Related Experiment Videos
Limitations of commercial test for antibody to hepatitis A virus
Lancet (London, England)
|January 27, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.
European journal of clinical pharmacology·2018
Activated Cellular Immunity in Chronic Hepatitis C.
Hematology (Amsterdam, Netherlands)·2016
Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.
Alimentary pharmacology & therapeutics·2015
Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.
Lancet (London, England)·2026
Interventional Radiology Society of Australasia Quality Care Guidelines for Prostate Artery Embolisation for Men With Symptomatic Benign Prostatic Hyperplasia in Australia and New Zealand.
Journal of medical imaging and radiation oncology·2026
Catheter-directed aspiration thrombectomy with the indigo system for intermediate- and high-risk pulmonary embolism in older patients: preliminary findings from a single-center experience.
Diagnostic and interventional radiology (Ankara, Turkey)·2026
Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions.
Journal of Alzheimer's disease : JAD·2026
Revisiting an overlooked biomarker: CSF-IgA demonstrates significant diagnostic value for viral encephalitis in a case-control study.
Frontiers in cellular and infection microbiology·2026